Vandenbroucke JP - Search Results

1

Neonatal screening and staggered early treatment for congenital dislocation or dysplasia of the hip.

Burger BJ, Burger JD, Bos CF, Obermann WR, Rozing PM, Vandenbroucke JP. Burger BJ, et al. Among authors: vandenbroucke jp. Lancet. 1990 Dec 22-29;336(8730):1549-53. doi: 10.1016/0140-6736(90)93317-i. Lancet. 1990. PMID: 1979375

2

Frejka pillow and Becker device for congenital dislocation of the hip. Prospective 6-year study of 104 late-diagnosed cases.

Burger BJ, Burger JD, Bos CF, Hermans J, Rozing PM, Vandenbroucke JP. Burger BJ, et al. Among authors: vandenbroucke jp. Acta Orthop Scand. 1993 Jun;64(3):305-11. doi: 10.3109/17453679308993632. Acta Orthop Scand. 1993. PMID: 8322587

3

A clinical epidemiological study in low back pain. Description of two clinical syndromes.

Collée G, Dijkmans BA, Vandenbroucke JP, Rozing PM, Cats A. Collée G, et al. Among authors: vandenbroucke jp. Br J Rheumatol. 1990 Oct;29(5):354-7. doi: 10.1093/rheumatology/29.5.354. Br J Rheumatol. 1990. PMID: 2145994

4

Mortality in hereditary antithrombin-III deficiency--1830 to 1989.

Rosendaal FR, Heijboer H, Briët E, Büller HR, Brandjes DP, de Bruin K, Hommes DW, Vandenbroucke JP. Rosendaal FR, et al. Among authors: vandenbroucke jp. Lancet. 1991 Feb 2;337(8736):260-2. doi: 10.1016/0140-6736(91)90867-o. Lancet. 1991. PMID: 1671110 Free article.

5

Evaluation of endoscopy for early detection of gastric-stump cancer.

Offerhaus GJ, Tersmette AC, Giardiello FM, Huibregtse K, Vandenbroucke JP, Tytgat GN. Offerhaus GJ, et al. Among authors: vandenbroucke jp. Lancet. 1992 Jul 4;340(8810):33-5. doi: 10.1016/0140-6736(92)92433-g. Lancet. 1992. PMID: 1351609

6

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Koster T, et al. Among authors: vandenbroucke jp. Lancet. 1993 Dec 18-25;342(8886-8887):1503-6. doi: 10.1016/s0140-6736(05)80081-9. Lancet. 1993. PMID: 7902898

7

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1994 Nov 26;344(8935):1453-7. doi: 10.1016/s0140-6736(94)90286-0. Lancet. 1994. PMID: 7968118 Free article.

8

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis.

ten Wolde S, Breedveld FC, Hermans J, Vandenbroucke JP, van de Laar MA, Markusse HM, Janssen M, van den Brink HR, Dijkmans BA. ten Wolde S, et al. Among authors: vandenbroucke jp. Lancet. 1996 Feb 10;347(8998):347-52. doi: 10.1016/s0140-6736(96)90535-8. Lancet. 1996. PMID: 8598699 Clinical Trial.

9

Postmenopausal oestrogen and cardioprotection.

Vandenbroucke JP. Vandenbroucke JP. Lancet. 1991 Apr 6;337(8745):833-4. doi: 10.1016/0140-6736(91)92526-8. Lancet. 1991. PMID: 1672923 No abstract available.

10

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: vandenbroucke jp. Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5. Lancet. 1995. PMID: 7500751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

626 results

Search Page

Filters